<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04083482</url>
  </required_header>
  <id_info>
    <org_study_id>WYJ2019</org_study_id>
    <nct_id>NCT04083482</nct_id>
  </id_info>
  <brief_title>Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis</brief_title>
  <official_title>Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First People's Hospital of Chenzhou</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First People's Hospital of Chenzhou</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The plasma level of mtDNA in sepsis is affected by continous venovenous hemofiltation（CVVH）
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Continous renal replacement therapy （CRRT）has become routine for patients with chronic renal
      failure ，AKI，fliud overload as well as oliguria in ICU .In clinical patients ，continous
      venovenous hemofoiltration （CVVH）is actually the method of chioce for CRRT in critically ill
      and hemodynamic instable patients .CVVH has significant beneficial effects on removing
      inflammatory cytokines ，improving oxygen index，increasing cardiac index and regulating immune
      dysfuntion .
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 20, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">September 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of mtDNA concentration in plasma</measure>
    <time_frame>befor,6hours, 12hours, after CVVH treatment</time_frame>
    <description>The specimens in the prefilter and postfilter blood as well as in the ultrafiltrate were obtained at the beginning of CRRT (T0) and 6 h (T6h), 12 h (T12h) after the setup of CVVH.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Intensive Care Unit</condition>
  <arm_group>
    <arm_group_label>Septic patients require CVVH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous venovenous hemofiltration. Continuous renal replacement therapy（CRRT）has become routine for patients with chronic renal failure ，AKI，fliud overload as well as oliguria in ICU .Continuous venovenous hemofiltration（CVVH）is the method of chioce for CRRT in critical ill .CVVH has significant beneficial effects on removing inflammatory cytokines ，improving oxygen index ，decreasing vasopressor requirements，increasing cardiac index and regulating immune dysfunction .</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continous venovenous hemofiltraion</intervention_name>
    <description>CVVH</description>
    <arm_group_label>Septic patients require CVVH</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult septic patients undergoing CRRT

        Exclusion Criteria:

          1. Missing vists

          2. transplatation

          3. cancer

          4. aquired immunodeficiency syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>dixian luo, MS</last_name>
    <role>Study Director</role>
    <affiliation>Chenzhou First people Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The First Hospital of Chenzhou</name>
      <address>
        <city>Chenzhou</city>
        <state>Hunan</state>
        <zip>450003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2019</study_first_posted>
  <last_update_submitted>September 5, 2019</last_update_submitted>
  <last_update_submitted_qc>September 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First People's Hospital of Chenzhou</investigator_affiliation>
    <investigator_full_name>Xingui Dai</investigator_full_name>
    <investigator_title>Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Mitochondrial DNA</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Continous venovenous hemofiltation</keyword>
  <keyword>Intensive Care Unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

